[{"address1": "7 Times Square", "address2": "43rd Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "929 999 4055", "website": "https://dianthustx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. The company's lead novel and proprietary monoclonal antibody product candidate includes DNTH103, a human monoclonal immunoglobulin G4 with picomolar that binds the active form of C1s, which is in clinical-stage trials for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.", "fullTimeEmployees": 78, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marino  Garcia M.B.A.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 943800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Savitz", "age": 35, "title": "Chief Financial Officer & Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 655479, "exercisedValue": 0, "unexercisedValue": 1149970}, {"maxAge": 1, "name": "Mr. Simrat  Randhawa M.B.A., M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 688600, "exercisedValue": 0, "unexercisedValue": 963050}, {"maxAge": 1, "name": "Mr. Edward G. Carr", "age": 55, "title": "Chief Accounting Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Judson  Taylor", "title": "Senior VP & Head of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer Davis Ruff", "title": "VP and Head of Investor Relations & Corporate Affairs.", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam M. Veness Esq.", "age": 38, "title": "Senior VP, General Counsel & Secretary", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristina  Maximenko", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rashieda  Gluck", "title": "Head of Clinical Development Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Nogi M.B.A.", "title": "Head of Business Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.98, "open": 18.96, "dayLow": 18.87, "dayHigh": 19.7, "regularMarketPreviousClose": 18.98, "regularMarketOpen": 18.96, "regularMarketDayLow": 18.87, "regularMarketDayHigh": 19.7, "payoutRatio": 0.0, "forwardPE": -5.981595, "volume": 171715, "regularMarketVolume": 171715, "averageVolume": 325679, "averageVolume10days": 476120, "averageDailyVolume10Day": 476120, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 626455040, "fiftyTwoWeekLow": 13.37, "fiftyTwoWeekHigh": 32.27, "priceToSalesTrailing12Months": 100.473946, "fiftyDayAverage": 20.5902, "twoHundredDayAverage": 24.7297, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 352690976, "profitMargins": 0.0, "floatShares": 14121907, "sharesOutstanding": 32125900, "sharesShort": 5288265, "sharesShortPriorMonth": 5423503, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.16459998, "heldPercentInsiders": 0.08068, "heldPercentInstitutions": 1.14195, "shortRatio": 14.16, "shortPercentOfFloat": 0.22389999, "impliedSharesOutstanding": 32125900, "bookValue": 11.328, "priceToBook": 1.7213984, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -84969000, "trailingEps": -2.55, "forwardEps": -3.26, "enterpriseToRevenue": 56.566, "enterpriseToEbitda": -3.466, "52WeekChange": -0.16092944, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 19.5, "targetHighPrice": 84.0, "targetLowPrice": 36.0, "targetMeanPrice": 52.6, "targetMedianPrice": 52.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 275240992, "totalCashPerShare": 8.568, "ebitda": -101768000, "totalDebt": 1491000, "quickRatio": 14.96, "currentRatio": 15.223, "totalRevenue": 6235000, "debtToEquity": 0.423, "revenuePerShare": 0.187, "returnOnAssets": -0.23008, "returnOnEquity": -0.32596, "grossProfits": 6235000, "freeCashflow": -43476000, "operatingCashflow": -78180000, "revenueGrowth": 1.902, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -24.06938, "financialCurrency": "USD", "symbol": "DNTH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "shortName": "Dianthus Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1744928984, "regularMarketTime": 1744920002, "exchange": "NCM", "messageBoardId": "finmb_631649032", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.7397285, "regularMarketPrice": 19.5, "fiftyTwoWeekLowChange": 6.13, "fiftyTwoWeekLowChangePercent": 0.45848918, "fiftyTwoWeekRange": "13.37 - 32.27", "fiftyTwoWeekHighChange": -12.77, "fiftyTwoWeekHighChangePercent": -0.39572358, "fiftyTwoWeekChangePercent": -16.092945, "earningsTimestamp": 1741723260, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.55, "epsForward": -3.26, "epsCurrentYear": -3.16, "priceEpsCurrentYear": -6.170886, "fiftyDayAverageChange": -1.0902004, "fiftyDayAverageChangePercent": -0.05294754, "twoHundredDayAverageChange": -5.2297, "twoHundredDayAverageChangePercent": -0.21147446, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "marketState": "CLOSED", "longName": "Dianthus Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": 2.41025, "postMarketPrice": 19.97, "postMarketChange": 0.469999, "regularMarketChange": 0.52000046, "regularMarketDayRange": "18.87 - 19.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 325679, "displayName": "Dianthus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]